Definitely yes on gene mutations; however, those where the disease has already appeared, or cancer that has occurred before will require another form of eradication/ prevention. And, that is where Quantum Biosystem technology will be effective in eliminating disease.
ALL inherited diseases could be cured within 20 years, a leading British expert claims.
It includes eradicating life-limiting conditions such as cystic fibrosis and Huntington’s disease.
Not too shock by this given other transplant patient’s stories of memories, etc.
There are a lot of outrageous claims being made within the halls of neuroscience and artificial intelligence. Whether exaggerations, wishful thinking, the dreams of the egocentric and megalomaniacal to be immortal, or just drumming up funding for a never-ending round of “scientific investigation,” the year 2045 seems to always be cited as a target date.
Ray Kurzweil popularized the notion of The Singularity – the threshold when computing power would match or exceed the human brain and human biological systems – in his 2006 book The Singularity is Near: When Humans Transcend Biology. In that book, and subsequent articles, he theorized that 2045 would be the far end of when we could expect full integration of human and machine that would create immortality.
A great Q&A, especially with the deathists that crop up.
Website ► http://sens.org
YouTube ► https://www.youtube.com/user/SENSFVideo
Facebook ► https://www.facebook.com/sensf
Twitter ► https://twitter.com/senstweet
SENS Research Foundation is a 501©(3) public charity that is transforming the way the world researches and treats age-related disease.
New research on Parkinson and holds additional insights in cell & neuro technology.
Autophagy functions as a main route for the degradation of superfluous and damaged constituents of the cytoplasm. Defects in autophagy are implicated in the development of various age-dependent degenerative disorders such as cancer, neurodegeneration and tissue atrophy, and in accelerated aging. To promote basal levels of the process in pathological settings, we previously screened a small molecule library for novel autophagy-enhancing factors that inhibit the myotubularin-related phosphatase MTMR14/Jumpy, a negative regulator of autophagic membrane formation. Here we identify AUTEN-99 (autophagy enhancer-99), which activates autophagy in cell cultures and animal models. AUTEN-99 appears to effectively penetrate through the blood-brain barrier, and impedes the progression of neurodegenerative symptoms in Drosophila models of Parkinson’s and Huntington’s diseases. Furthermore, the molecule increases the survival of isolated neurons under normal and oxidative stress-induced conditions. Thus, AUTEN-99 serves as a potent neuroprotective drug candidate for preventing and treating diverse neurodegenerative pathologies, and may promote healthy aging.
Nice.
A suite of flexible and biocompatible threads, embedded with sensors and electronics, can be sutured/woven into tissue for in situ measurements of physical and chemical biomarkers.
Real-time monitoring of chronic or surgical wounds for signs of infection or inflammation can drastically improve the health outcomes from these issues. Such monitoring requires that sensors be embedded deep within the tissue. In addition, the acquired information needs to be communicated to the doctor/caregiver so that patient-specific treatments can be optimized. Although recent miniaturization of sensors, as well as the fabrication of smart materials, has allowed the development of the necessary devices (e.g., electrocardiogram electrodes, temperature sensors, pH sensors, and flexible batteries) to continuously monitor a patient’s health status,1–5 there are still several challenges that need to be overcome. Such problems include the mismatch between mechanical and topographical properties of semiconductor-based electronics and biological tissues, as well as flexibility and biocompatibility issues.
[Brain implant experiments] like those that let a paralyzed person swig coffee using a robotic arm, or that let blind people “see” spots of light, have proven the huge potential of computers that interface with the brain. But the implanted electrodes used in such trials eventually become useless, as scar tissue forms that degrades their electrical connection to brain cells.
[However,] tests will begin in monkeys of a new implant for piping data into the brain that is designed to avoid that problem. [Led by Harvard researchers,] the project is intended to lead to devices that can restore vision to blind people long-term…[The device will] go beneath the skull but can rest on the surface of an animal’s brain, instead of penetrating inside the organ.
Russian author Boris Zhitkov wrote the 1931 short story Microhands, in which the narrator creates miniature hands to carry out intricate surgeries. And while that was nearly 100 years ago, the tale illustrates the real fundamentals of the nanoscience researchers are working on today.
Nanoscience is the study of molecules that are one billionth of a metre in size. To put this into perspective, a human hair is between 50,000 and 100,000 nanometres thick. At this tiny size, materials possess properties that lie somewhere between a lump of metal and that of a single atom. This unique environment means they can become very reactive and be used as catalysts.
The ideas behind nanoscience are often easier to understand when considered simply in terms of how a single material’s properties change. But the field is not limited to just that: we are now moving into the realm of healthcare therapies, and vehicles smaller than a speck of dust. What were once regarded as science fictions are rapidly becoming fact.
The problems that I have seen when limiting the topic of quantum mechanics to the human mind topic is that the relationship around Quantum Mechanics to biology is missed completely. For example, it has only be in the recent few years that scientists began to understand Quantum Mechanics Action of ELF electromagnetic fields and its relationship to human cells. And, this find has open valuable research in how cells can (through electromagnetic fields can spin a low temperatures) mimic telepathy communicating between the human cells.
Nobody understands what consciousness is or how it works. Nobody understands quantum mechanics either. Could that be more than coincidence?
The Broad Institute in Cambridge, Mass., will retain potentially lucrative rights to a powerful gene-editing technique that could lead to major advances in medicine and agriculture, the federal Patent and Trademark Office ruled on Wednesday.
The decision, in a bitterly fought dispute closely watched by scientists and the biotechnology industry, was a blow to the University of California, often said to be the birthplace of the technique, which is known as Crispr-Cas9.
An appeals board of the patent office ruled that the gene-editing inventions claimed by the two institutions were separate and do not overlap.
